Seòmar agus comataidhean

Based on 2024 estimates, Crown Estate Scotland projects a revenue from ScotWind developments of £3.42m per gigwatt over the lifetime of the project. If leased through ScotWind then Inch Cape (1.08GW installed capacity) would return £3.7m annually.

The figures provided are estimates only – actual revenues achieved will be dependent on a range of issues, including those affecting deployment scale, and timing and windspeeds.

Decisions on the Review of Electricity Market Arrangements (REMA) are reserved to the UK Government. The UK Government has published impact assessments and is updating its analysis ahead of a final decision this summer. We are awaiting sight of this updated modelling.

It is a matter for Health Boards to consider the implementation of any new medicine to meet the needs of their local population. However, in response to concerns raised regarding access to givinostat in Scotland, the Cabinet Secretary has met with the four health boards who provide regional services across Scotland for children and adults with neuromuscular disorders, including Duchenne muscular dystrophy (DMD). He has asked them to set out their timelines and approaches to the families who have children with DMD in the next two weeks. In addition, the Chief Pharmaceutical Officer has been assured that the consultants have reviewed all those who eligible to ensure fair and equitable access across Scotland.

The First Minister announced to the Scottish Parliament on 6 May 2025 that we intend to remove the ban on alcohol on trains and replace it with new restrictions which will allow alcohol consumption between from 10am to 9pm every day. ScotRail will reserve the right to implement alcohol restrictions on specific services where BTP and rail industry intelligence indicates it necessary, for example major concerts or sporting events.

The current ban will be lifted and the new rules will come into force on 2 June 2025.

The Scottish Budget: 2025-26 published on 4 December 2024 allocated £46.0 million of capital to Ferguson Marine for the financial year commencing 1 April 2025 (with details in Table 9.13: Ferguson Marine Spending Plans (Level 3).

This allocation is designed to cover capital spending associated with completion of the MV Glen Rosa and investment in yard capital equipment and infrastructure in the current financial year. Over the current and next financial years, 2025-26 and
2026-27, the Scottish Government is committed to invest up to £14.2 million in Ferguson Marine’s investment programme subject to standard commercial tests being met.

Work on Ferguson’s investment programme began in December 2024, with approved funding being directed towards addressing essential repairs and new equipment to enhance yard productivity.

There are existing protections for freedom of speech and the Equality Act 2010 protects people from discrimination or harassment at work or in other areas of their life, because of their religious or philosophical beliefs.

The Equality Act 2010 is mainly reserved to the UK Parliament and UK Government. The regulator, the Equality and Human Rights Commission, has issued guidance on avoiding discrimination and harassment in the workplace and there is a Statutory Code of Practice on Employment.

Freedom of speech is a qualified right and the ways in which a person’s religion or belief is manifested might not be protected if this impacts on the legal rights of others, including those with the protected characteristic of gender reassignment, not to be discriminated against or harassed.

At launch we substantially widened eligibility for Funeral Support Payment in comparison to the UK Government’s funeral payment. We recognised the complex nature of family relationships and introduced flexibility, meaning that the applicant does not have to be the closest relative of the deceased.

We regularly consider how to improve our payments and last year introduced amendment regulations to make improvements to Funeral Support Payment, further supporting bereaved people and helping people who are struggling to pay for a funeral. The changes included extending the definition of funeral to include alkaline hydrolysis, providing assistance for funerals abroad in exceptional circumstances and removing the cap for funerals outwith the deceased’s local area.

The information requested is not held centrally by the Scottish Government and is a matter for individual public bodies. The Equalities and Human Rights Commission (EHRC) is the body responsible for regulating and enforcing the Equality Act 2010. The Scottish Government is already undertaking a review of existing policies, guidance and legislation impacted by the recent Supreme Court judgment but will require to fully consider the revised Guidance and Code from the EHRC when it is issued, along with the Supreme Court judgment itself, before any changes could be made.

Recent research suggests vaccination for shingles with the live attenuated herpes zoster vaccine (Zostavax®) could be linked to a reduction in the risk of developing dementia.

In the UK, Zostavax®, a live vaccine, was routinely offered to those eligible for the NHS shingles programme and not contraindicated to the vaccine.

In February 2019, the Joint Committee on Vaccination and Immunisation recommended that Shingrix® a non-live vaccine, should replace Zostavax® in the routine programme and since 1 September 2023, all newly eligible individuals have been offered the non-live shingles vaccine Shingrix®.

The Shingles vaccination programme was first introduced in Scotland in 2013. In 2023, the Joint Committee on Vaccination and Immunisation (JCVI) recommended the use of a new two-course vaccine and the expansion of the age cohorts to protect individuals at an earlier age. They recommended a phased implementation over ten years. Currently, individuals who are age 65 and 70, over age 50 with a severely weakened immune system and people with certain health conditions are eligible for two doses of shingles vaccine. The second dose is usually offered between 2 and 12 months after the first. Eligible individuals will be contacted by their local NHS Immunisation team. Most Immunisation teams begin inviting patients forward from January onwards.

In due course, those who reach age 60 or 65 years during the period 1 September 2028 to 31 August 2033 will become eligible from 1 September in the relevant year.